Rodgers Richard J is a director of Ocuphire Pharma Inc.
Person profile
Roles
Address
Waltham, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Ocuphire Pharma, Inc.
3 Jan 24
4
Ocuphire Pharma, Inc.
13 Nov 23
4
NOVAVAX INC
31 Oct 23
4
Sagimet Biosciences Inc.
20 Jul 23
3
Sagimet Biosciences Inc.
13 Jul 23
4
ARDELYX, INC.
16 Jun 23
4
NOVAVAX INC
13 Jun 23
4
Ocuphire Pharma, Inc.
21 Apr 23
4
Ocuphire Pharma, Inc.
12 Jan 23
4
NOVAVAX INC
1 Nov 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Jan 24 | OCUP Ocuphire Pharma | Common Stock | Grant | Acquire A | No | No | 0 | 24,762 | 0.00 | 198,008 |
1 Nov 23 | OCUP Ocuphire Pharma | Common Stock | Grant | Acquire A | No | No | 0 | 35,000 | 0.00 | 173,246 |
29 Oct 23 | NVAX Novavax | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,800 | 0.00 | 3,800 |
29 Oct 23 | NVAX Novavax | RSU Restricted Stock Units | Option exercise | Dispose M | No | No | 0 | 3,800 | 0.00 | 7,600 |
18 Jul 23 | SGMT Sagimet Biosciences | Stock Option Series A Common Stock | Grant | Acquire A | No | No | 6.36 | 23,839 | 151.62 k | 23,839 |
18 Jul 23 | SGMT Sagimet Biosciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.36 | 23,839 | 151.62 k | 0 |
18 Jul 23 | SGMT Sagimet Biosciences | Stock Option Series A Common Stock | Grant | Acquire A | No | No | 6.36 | 23,216 | 147.65 k | 23,216 |
18 Jul 23 | SGMT Sagimet Biosciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.36 | 23,216 | 147.65 k | 0 |
18 Jul 23 | SGMT Sagimet Biosciences | Stock Option Series A Common Stock | Grant | Acquire A | No | No | 23.05 | 1,976 | 45.55 k | 1,976 |
18 Jul 23 | SGMT Sagimet Biosciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 23.05 | 1,976 | 45.55 k | 0 |